MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about JNJ

Recent news which mentions JNJ

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
32 33 Next >
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Tickers JNJ NEWS
Tags Most Accurate Analysts JNJ Analyst Ratings
From Benzinga
This Is What Whales Are Betting On Johnson & Johnson
Tickers JNJ
Tags Markets JNJ Options
From Benzinga
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
Tickers JNJ LLY NEWS
Tags Equities JNJ General
From Benzinga
Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals
Tickers JNJ NEWS
Tags News Expert Ideas Health Care
From Benzinga
Columbus Day: Is Stock Market Open Today?
Tickers ABT BAC JNJ NEWS
Tags Market News NASDAQ Benzinga
From Benzinga
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
Tickers AMZN CHD CLX JNJ
Tags PEP UL CLX
From Motley Fool
Market Whales and Their Recent Bets on JNJ Options
Tickers JNJ
Tags Benzinga BZI/UOA Options
From Benzinga
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Tickers BX GS GSK HLN
Tags Benzinga Briefs Market News
From Benzinga
What Analysts Are Saying About Johnson & Johnson Stock
Tickers JNJ
Tags Analyst Ratings BZI/AAR Benzinga
From Benzinga
Insights Into Johnson &amp; Johnson's Performance Versus Peers In Pharmaceuticals Sector
Tickers JNJ NEWS
Tags Market News BZI/IA Benzinga
From Benzinga
1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income
Tickers AAPL AVGO JNJ JPM
Tags JPM AVGO V
From Motley Fool
What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week?
Tickers JNJ NEWS
Tags General Stories That Matter Analyst Color
From Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
Tickers JNJ NEWS TAK
Tags Briefs Benzinga TAK
From Benzinga
2 Smart Income Stocks to Buy Right Now
Tickers JNJ KO
Tags Market News JNJ KO
From Motley Fool
Johnson & Johnson's Options: A Look at What the Big Money is Thinking
Tickers JNJ
Tags Options Market News Markets
From Benzinga
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Tickers JNJ NEWS PFE
Tags Biotech General Market News
From Benzinga
Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients
Tickers JNJ LEGN NEWS
Tags JNJ Equities Analyst Ratings
From Benzinga
2 Excellent Dividend Stocks to Buy With Less Than $200
Tickers ABT JNJ
Tags Market News JNJ Recent Press Releases
From Motley Fool
Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment
Tickers JNJ NEWS
Tags Health Care News Large Cap
From Benzinga
In-Depth Analysis: Johnson &amp; Johnson Versus Competitors In Pharmaceuticals Industry
Tickers JNJ NEWS
Tags Trading Ideas News Markets
From Benzinga
Why Masimo Stock Crushed the Market Today
Tickers JNJ KFY MASI
Tags JNJ Market News Recent Press Releases
From Motley Fool
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Tickers GS GSK HLN JNJ
Tags MS GS M&A
From Benzinga
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Tickers ABT JNJ
Tags ABT Recent Press Releases JNJ
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers BHVN BMY BNTX CI
Tags BHVN GMED BZI/AUOA
From Benzinga
Is Johnson & Johnson Stock a Buy?
Tickers JNJ
Tags JNJ Market News Recent Press Releases
From Motley Fool
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
Tickers JNJ NEWS
Tags Biotech Market News Briefs
From Benzinga
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
Tickers JNJ NEWS ZVRA
Tags General Stories That Matter FDA
From Benzinga
The Latest Analyst Ratings For Johnson & Johnson
Tickers JNJ
Tags JNJ Market News Analyst Ratings
From Benzinga
2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement
Tickers AAPL AMZN AVGO GOOG
Tags NVDA JNJ AVGO
From Motley Fool
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
Tickers AZN BGNE JNJ NEWS
Tags Health Care Initiation News
From Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story